深转交债

002382

511380

<p>The actual controller of BLUE SAIL MEDICAL, Li Zhenping, plans to lend the company 350 million yuan to optimize its capital and debt structure. The company recently disclosed two acquisitions, demonstrating its efforts for self-rescue. However, BLUE SAIL MEDICAL has reported losses for four consecutive years, and the performance forecast for 2025 indicates that the net profit loss will expand to between 650 million and 850 million yuan, with short-term debts exceeding 4.4 billion yuan, increasing repayment pressure. On March 17, the conversion price of BLUE SAIL MEDICAL's convertible bonds was adjusted down to 7.95 yuan per share, marking the eighth adjustment since 2024</p>

深转交债(399290.SZ)

Li Zhenping's 350 million yuan and Blue Sail Medical's "amputation" moment